This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jubilant Episcribe LLC. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovator Raghunadha Reddy Burri: A Beacon of Progress in Therapeutics
Introduction: Raghunadha Reddy Burri, based in Bengaluru, India, is a notable inventor recognized for his contributions to the field of medicinal chemistry. He holds a significant patent that addresses crucial therapeutic challenges associated with various diseases. His innovative approach combines scientific expertise with practical applications, demonstrating the potential impact of his work on healthcare.
Latest Patents: Raghunadha Reddy Burri has been granted one patent titled "Heterocyclic compounds as PRMT5 inhibitors." The patent specifically covers compounds of Formula I, Formula Ia, and Formula Ib, along with their analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs. These compounds target the PRMT5 enzyme and exhibit potential as therapeutic agents for conditions such as malignant tumors, schizophrenia, Alzheimer’s disease, and Parkinson’s disease.
Career Highlights: Raghunadha is currently employed at Jubilant Episcribe LLC, where he applies his expertise in chemical research to develop innovative solutions in the pharmaceutical sector. His work reflects a strong commitment to enhancing therapeutic efficacy and improving patient outcomes.
Collaborations: In his professional journey, Raghunadha collaborates with esteemed colleagues such as Saravanan Vadivelu and Sridharan Rajagopal. These partnerships exemplify the collaborative spirit of innovation within the research environment, fostering the exchange of ideas and propelling forward the boundaries of science.
Conclusion: Raghunadha Reddy Burri stands out as an inspiring inventor whose groundbreaking work in developing PRMT5 inhibitors showcases the power of innovation in addressing complex health issues. His contributions continue to pave the way for advancements in therapeutic strategies, highlighting the vital role of inventors in shaping the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile